These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 11517203)
1. Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275 000 babies. Carpenter K; Wiley V; Sim KG; Heath D; Wilcken B Arch Dis Child Fetal Neonatal Ed; 2001 Sep; 85(2):F105-9. PubMed ID: 11517203 [TBL] [Abstract][Full Text] [Related]
2. Screening for medium chain acyl-CoA dehydrogenase deficiency using electrospray ionisation tandem mass spectrometry. Clayton PT; Doig M; Ghafari S; Meaney C; Taylor C; Leonard JV; Morris M; Johnson AW Arch Dis Child; 1998 Aug; 79(2):109-15. PubMed ID: 9797589 [TBL] [Abstract][Full Text] [Related]
3. Neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency. Pourfarzam M; Morris A; Appleton M; Craft A; Bartlett K Lancet; 2001 Sep; 358(9287):1063-4. PubMed ID: 11589939 [TBL] [Abstract][Full Text] [Related]
4. Lack of genotype-phenotype correlations and outcome in MCAD deficiency diagnosed by newborn screening in New York State. Arnold GL; Saavedra-Matiz CA; Galvin-Parton PA; Erbe R; Devincentis E; Kronn D; Mofidi S; Wasserstein M; Pellegrino JE; Levy PA; Adams DJ; Nichols M; Caggana M Mol Genet Metab; 2010 Mar; 99(3):263-8. PubMed ID: 20036593 [TBL] [Abstract][Full Text] [Related]
5. Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency. Andresen BS; Dobrowolski SF; O'Reilly L; Muenzer J; McCandless SE; Frazier DM; Udvari S; Bross P; Knudsen I; Banas R; Chace DH; Engel P; Naylor EW; Gregersen N Am J Hum Genet; 2001 Jun; 68(6):1408-18. PubMed ID: 11349232 [TBL] [Abstract][Full Text] [Related]
6. Medium chain acyl-CoA dehydrogenase deficiency in Pennsylvania: neonatal screening shows high incidence and unexpected mutation frequencies. Ziadeh R; Hoffman EP; Finegold DN; Hoop RC; Brackett JC; Strauss AW; Naylor EW Pediatr Res; 1995 May; 37(5):675-8. PubMed ID: 7603790 [TBL] [Abstract][Full Text] [Related]
7. Rapid diagnosis of MCAD deficiency: quantitative analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry. Chace DH; Hillman SL; Van Hove JL; Naylor EW Clin Chem; 1997 Nov; 43(11):2106-13. PubMed ID: 9365395 [TBL] [Abstract][Full Text] [Related]
8. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency: performance improvement by monitoring a new ratio. Hall PL; Wittenauer A; Hagar A Mol Genet Metab; 2014 Dec; 113(4):274-7. PubMed ID: 25454677 [TBL] [Abstract][Full Text] [Related]
12. Prevalence and mutation analysis of short/branched chain acyl-CoA dehydrogenase deficiency (SBCADD) detected on newborn screening in Wisconsin. Van Calcar SC; Baker MW; Williams P; Jones SA; Xiong B; Thao MC; Lee S; Yang MK; Rice GM; Rhead W; Vockley J; Hoffman G; Durkin MS Mol Genet Metab; 2013; 110(1-2):111-5. PubMed ID: 23712021 [TBL] [Abstract][Full Text] [Related]
13. Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency: a global perspective. Rhead WJ J Inherit Metab Dis; 2006; 29(2-3):370-7. PubMed ID: 16763904 [TBL] [Abstract][Full Text] [Related]
14. Screening of the most common medium-chain acyl CoA dehydrogenase (MCAD) deficiency mutation (K329E) in the Czech newborn population. Kozàk L; Hrabincovà E; Rudolfoà J; Vràbelovà S; Freiberger T Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():49-50. PubMed ID: 11400780 [TBL] [Abstract][Full Text] [Related]
15. Blood acylcarnitine levels in normal newborns and heterozygotes for medium-chain acyl-CoA dehydrogenase deficiency: a relationship between genotype and biochemical phenotype? Lehotay DC; LePage J; Thompson JR; Rockman-Greenberg C J Inherit Metab Dis; 2004; 27(1):81-8. PubMed ID: 14970748 [TBL] [Abstract][Full Text] [Related]
16. Medium-chain acyl-CoA dehydrogenase deficiency: postmortem diagnosis in a case of sudden infant death and neonatal diagnosis of an affected sibling. Bennett MJ; Rinaldo P; Millington DS; Tanaka K; Yokota I; Coates PM Pediatr Pathol; 1991; 11(6):889-95. PubMed ID: 1775402 [TBL] [Abstract][Full Text] [Related]
18. Newborns with C8-acylcarnitine level over the 90th centile have an increased frequency of the common MCAD 985A>G mutation. Blois B; Riddell C; Dooley K; Dyack S J Inherit Metab Dis; 2005; 28(4):551-6. PubMed ID: 15902558 [TBL] [Abstract][Full Text] [Related]
19. A novel mutation in medium chain acyl-CoA dehydrogenase causes sudden neonatal death. Brackett JC; Sims HF; Steiner RD; Nunge M; Zimmerman EM; deMartinville B; Rinaldo P; Slaugh R; Strauss AW J Clin Invest; 1994 Oct; 94(4):1477-83. PubMed ID: 7929823 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic and therapeutic implications of medium-chain acylcarnitines in the medium-chain acyl-coA dehydrogenase deficiency. Roe CR; Millington DS; Maltby DA; Bohan TP; Kahler SG; Chalmers RA Pediatr Res; 1985 May; 19(5):459-66. PubMed ID: 4000772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]